Boehringer Ingelheim completes Koropi plant expansion, targets high-value pharma exports

Boehringer Ingelheim completed a new wing at its Koropi, Greece facility, part of a €120M investment plan (2023-2027) focused on high-value pharmaceuticals. Production start date not specified. The expansion supports exports to 90 countries, signaling continued investment in Greece's pharma manufacturing base.